Clinical Trials Directory

Trials / Completed

CompletedNCT02314936

Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation

Dose-ranging Efficacy of Supplementation With Polydextrose, a Dietary Fibre, on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebo-controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
192 (actual)
Sponsor
KGK Science Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study will investigate the effectiveness of Polydextrose, a dietary fiber, at decreasing Colonic Transit Time and the gastrointestinal symptoms of Functional Constipation. One quarter of the subjects will receive 12 g of Polydextrose daily, one quarter will receive 8 g of Polydextrose daily, one quarter will receive 4 g of Polydextrose daily and one quarter will receive a placebo daily.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLitesse powder containing 12 g polydextrose12 g polydextrose
DIETARY_SUPPLEMENTLitesse powder containing 8 g polydextrose8 g polydextrose, 4 g maltodextrin
DIETARY_SUPPLEMENTLitesse powder containing 4 g polydextrose4 g polydextrose, 8 g maltodextrin
DIETARY_SUPPLEMENTPlacebo12 g Maltodextrin

Timeline

Start date
2015-04-01
Primary completion
2016-04-01
Completion
2016-05-01
First posted
2014-12-11
Last updated
2018-11-09
Results posted
2018-11-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02314936. Inclusion in this directory is not an endorsement.